Who gets paid for what? Slow progress on EU PV fees
This article was originally published in Scrip
Executive Summary
Despite the radical changes made by the European Commission to its proposals for a new pharmacovigilance fee structure, a number of outstanding issues remain to be resolved before the draft Regulation can be approved.